Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Shares in Novo Nordisk plunged as much as 30% after the Danish drugmaker cut its guidance and named a new chief executive, as it pins its hopes on a company veteran to revive growth.The company said ...

Copenhagen-listed shares of Novo Nordisk plunged more than 21% on Tuesday after the Danish pharmaceutical company issued a profit warning, citing weaker-than-expected sales growth for its flagship ...